EGFR and cancer: It has been recently described that derailed endocytosis is an emerging feature of cancer [28,29] and receptor down-regulation induced by anti-EGFR MAbs was described as an important mechanisms responsible for growth factor receptors inactivation and termination of EGFR cascade signaling [17,28-32].